Gamma Vaccines signs licence agreement with Griffith University to commercialise Chikungunya vaccine.

Gamma Vaccines has been granted a worldwide exclusive licence to commercialize a patented Chikungunya vaccine from Griffith University, OLD, which includes the rights to sublicence this technology.

Share this post

18/03/2025
Gamma Vaccines Changes its Status to a Public Company Limited by Shares
Gamma Vaccines announces that it has changed its status from a Private Company limited by shares to a…

Read article
05/10/2024
Gamma Vaccines acquires IP to develop NDV vaccine
Gamma Vaccines has signed a deed of assignment with the University of Adelaide for the rights to commercialise…

Read article
12/09/2024
Gamma vaccines signs international collaboration agreement.
Gamma vaccines has entered a collaboration agreement with Capricorn Technologies GmBH (Austria) and Aptum Adjuvants Ltd (UK) to…

Read article

View All Articles

Gamma Vaccines signs licence agreement with Griffith University to commercialise Chikungunya vaccine.

Share this post

Related Articles

Gamma Vaccines Changes its Status to a Public Company Limited by Shares

Gamma Vaccines acquires IP to develop NDV vaccine

Gamma vaccines signs international collaboration agreement.